Daily Brief Archive: August 7, 2026 — U.S. & Hong Kong Stock Analysis

Free preview

U.S. Markets

  • The Dow fell 0.9%, ending a five-day streak; S&P -0.2%, Nasdaq -0.1%
  • Index moves were mild while single-name earnings were slaughtered
  • HONA -23.2%: a $300M guidance cut as casting shortages choke aftermarket
  • APP -19.7%, DDOG -19.0% and HUBS -19.1% all cratered the same day
  • WDC -13.0%: falling NAND spot pricing outweighed an earnings beat
  • Rising Treasury yields plus firmer crude marked the first ebb in risk appetite

Hong Kong

  • The Hang Seng fell 1.49% to 25,530.28; HS Tech -2.28%
  • Southbound flows flipped to net selling of HK$1.46B
  • Platforms fell broadly: Baidu -4%, Alibaba -2.89%, Tencent -2.64%
  • HK memory names fell in sympathy with WDC stateside
  • AI model names bucked the tape: MiniMax +17%, Zhipu +4%
  • Coal and TCM names firmed as money rotated defensive

Today's Watchlist

  • SNDK grew revenue 372% at an 84.6% gross margin, yet fell 6.81%
  • Falling NAND spot pricing is the memory chain's core variable today
  • SNDK's multiple compressed to 17.3x post-earnings, a valuation reset
  • Beats punished again: guidance now outweighs the quarter itself
  • INSM +33.9% on TPIP data and peak sales guidance above $14B
  • SPCX +6.14% as the lockup supply shock failed to materialize

Deep Dives (3 names)

Long
Score8/10RSI(14) 68.91-week gain +13.3%P/E TTM 21.5EPS growth TTM +65.7%Consensus upside +20.1%

Technicals — It closed at HK$178.00, down 0.95%, falling less than the broad market on a day the Hang Seng dropped 1.49% and HS Tech 2.28% — solid relative strength. Price holds above the 50-day (HK$146.36) and 200-day (HK$122.24) in a complete bullish stack. RSI(14) eased from 76.3 to 68.9 and RSI(7) from 86.7 to 71.2, materially relieving overbought pressure — exactly the healthy digestion anticipated when yesterday's note warned that any good news landing could trigger profit-taking. The week is still up 13.3% and price sits just 5.2% below the HK$187.80 high. ATR is HK$7.92.

Fundamentals — First-half 2026 revenue of RMB28.90B grew 38.93% with net profit of RMB11.08B up 29.43%, crossing RMB10B for a half year for the first time, while full-year revenue guidance rose from RMB51.3–53.0B to RMB58.5–60.5B. The stock trades at 21.5x trailing earnings with EPS up 65.7%, revenue up 29.9% and a 52.6% gross margin. Consensus targets have climbed from HK$188.77 on 8/4 to HK$208.74 on 8/5 and now HK$213.85 — two raises in three days, showing analysts still catching up to the guidance revision. Huachuang Securities has noted that warming pharma investment and financing globally should transmit CRO front-end order growth into earnings.

News — Hong Kong weakened across the board on 8/6: the Hang Seng fell 1.49% to 25,530.28 and HS Tech 2.28%, with platforms broadly lower — Baidu -4%, Alibaba -2.89%, Tencent -2.64%, Xiaomi -2.82% — while southbound flows turned to net selling of HK$1.46B, the first flip from buying in recent sessions. Against that, WuXi AppTec fell only 0.95%. The prior session on 8/5 had seen its H-shares gain more than 11% and its A-shares hit limit-up at a five-year high, adding over RMB38B of market value in a day. TCM and innovative-drug names were among the few directions attracting money that day.

Short-term · 1–3 weeks
Long Lean bullish

Maintaining the long. Today's signal is healthy: RSI(7) fell from 86.7 to 71.2, digesting the overbought condition while price gave up only 0.95% — far better than working it off through a selloff. Falling less than the index on a day the Hang Seng dropped 1.49% and southbound flipped to selling indicates a stable shareholder base. The entry guidance shifts from yesterday's do-not-add to an actual HK$168–176 pullback zone (the earlier HK$168–175 was never touched), the stop stays at HK$162, and the target rises to HK$213 following consensus up from HK$208. RSI at 68.9 is still elevated, which is why this stays lean bullish rather than bullish.

Entry HK$168~176Stop HK$162Target HK$213
Long-term · months+
Accumulate

A backlog up 25.2% provides two years of revenue visibility, Q2 growth accelerated to 47.71%, and full-year guidance was raised by more than RMB7B in one step. Warming global pharma financing is transmitting into orders, making this an industry cycle rather than a single-company story. At 21.5x against 65.7% EPS growth the valuation remains reasonable.

  • US biosecurity legislation is a permanent tail risk for the sector
  • Southbound flows flipped to selling, weakening the overall Hong Kong liquidity backdrop
  • Just 5.2% below its 52-week high, with little reference above beyond untested territory
Signal BacktestCumulative -1.98%price itself -1.98%profitable since 08-05
  • 08-04LongHK$181.6 → open → HK$178-1.98%
Community Voices
  • 港股通 · Southbound flipped to net selling of HK$1.46B, yet pharma was among the few directions that firmed. What money keeps while it is trimming says more than what it buys while addingOriginal ↗
Institutional Views
  • 华尔街共识 · 18 analysts average a HK$213.85 target, about 20.1% above spot, at a 1.08 rating near strong buy — raised successively from HK$188.77 over three days
Long
Score7/10RSI(14) 63.8HK session -2.89%P/E TTM 20.81-month gain +29.3%Consensus upside +47.5%

Technicals — It closed at HK$125.40, up 0.80% on this cross-timezone snapshot basis, while the local Hong Kong session on 8/6 fell 2.89%. Price holds above the 50-day (HK$111.45) but remains 8.8% below the 200-day (HK$137.56) — still the key unreclaimed gate, and a wider gap than the 7.5% of the prior two sessions. RSI(14) eased from 68.9 to 63.8 and RSI(7) from 79.6 to 67.8, relieving overbought pressure. The week is up 9.9% and the month 29.3%, a 41.5% recovery from the HK$88.65 low. ATR is HK$4.88.

Fundamentals — It trades at 20.8x trailing earnings with EPS down 16.7%, revenue growth of just 4.6% and a 39.3% gross margin — the reported fundamentals remain unremarkable, and this rally is priced off an AI asset rerating rather than the current income statement. The Qwen3.8 model released on 8/3 carries 2.4 trillion parameters and ranks second only to Anthropic's Claude series on the third-party Arena leaderboard. The HK$184.97 consensus target implies 47.5% upside, the highest among today's Hong Kong names and wider than yesterday's 45.0% as the price pulled back.

News — Hong Kong platform stocks weakened across the board on 8/6, with Alibaba down 2.89% in the local session alongside Baidu off more than 4%, Tencent -2.64%, JD -2.08% and Xiaomi -2.82%, as the HS Tech index fell 2.28% to 4,820.78. The notable shift was in flows: southbound turned to net selling of HK$1.46B, a sharp reversal from 8/4 when Alibaba led turnover on both the Shanghai and Shenzhen channels. The names that firmed were pure AI model plays — MiniMax up more than 17% and Zhipu up 4% — so money didn't leave the AI theme, it rotated from large platforms into model-native names.

Short-term · 1–3 weeks
Long Lean bullish

Maintaining the long but stepping down from bullish to lean bullish — on flows rather than fundamentals. Southbound flipped to net selling of HK$1.46B and money visibly rotated from large platforms into pure model names like MiniMax and Zhipu, meaning the rerating momentum from Qwen3.8 is being diluted within Hong Kong itself. The 200-day at HK$137.56 remains unreclaimed and the gap widened from 7.5% to 8.8%, which is the wrong direction. Entry at HK$118–124 and the stop at HK$112 below the 50-day hold, while the target trims from HK$140 to HK$137 to align with the 200-day. A 20.8x multiple and 47.5% consensus upside still justify holding, but adding waits for southbound flows to return.

Entry HK$118~124Stop HK$112Target HK$137
Long-term · months+
Accumulate

The closed loop of owned cloud, self-trained models and commerce monetization is unique in China, and Qwen3.8's Arena ranking gives it a verifiable technical foundation. At 20.8x with 47.5% consensus upside, room for valuation repair remains.

  • Southbound flows flipped to selling and rotated visibly toward pure model names
  • Trailing EPS is down 16.7%; the AI narrative has not reached earnings
  • The 200-day remains unreclaimed with the gap widening, leaving the intermediate trend unconfirmed
Signal BacktestCumulative +25.37%price itself +33.26%0/1 closed trades wonprofitable since 07-09
  • 07-02LongHK$94.5 → closed HK$94.107-04-0.42%
  • 07-08LongHK$99.6 → open → HK$125.4+25.90%
Community Voices
  • 港股通 · Topped southbound turnover on both channels three days ago; today the whole market saw HK$1.46B of net selling. Same money, two faces. It rotated into MiniMax and Zhipu, which says it wants pure model exposure, not a model carrying an e-commerce business on its backOriginal ↗
Institutional Views
  • 华尔街共识 · 33 analysts average a HK$184.97 target, roughly 47.5% above spot, at a 1.17 rating near strong buy
Long
Score7/10RSI(14) 55.8HK session -2.64%P/E TTM 17.2EPS growth TTM +21.3%Consensus upside +44.1%

Technicals — It closed flat at HK$479.20 on this cross-timezone snapshot basis, while the local Hong Kong session on 8/6 fell 2.64%. Price holds above the 50-day (HK$454.16) but sits 11.7% below the 200-day (HK$535.36), a gap that widened noticeably from 8.9% two sessions ago. RSI(14) eased from 60.7 to 55.8 and RSI(7) from 68.5 to 56.3, returning to neutral — amid today's field of extreme overbought and deeply oversold readings, Tencent's position remains among the least worrying. The week is up 2.0% and the month 3.9%, with an ATR of HK$15.48 and the 50-day at HK$454.16 as the nearest structural support.

Fundamentals — It trades at 17.2x trailing earnings with EPS up 21.3%, revenue up 15.0% and a 54.8% gross margin, putting the PEG well below 1 — the best growth-to-valuation match in today's field. Fifty-three analysts average a HK$690.65 target implying 44.1% upside at a 1.14 rating, an unusually tight consensus, with the gap wider than yesterday's 41.2% after the price eased. Tencent's central tension is unchanged: the fundamentals are beyond reproach but there is no catalyst to force a rerating — and today's rotation into pure model names like MiniMax and Zhipu bypassed it once again.

News — Tencent fell 2.64% in the local Hong Kong session on 8/6, tracking the HS Tech index down 2.28% alongside the broader platform complex. Baidu fell more than 4%, Alibaba 2.89%, JD 2.08% and Xiaomi 2.82%, while southbound flows turned to net selling of HK$1.46B. The names that rose were AI model plays — MiniMax up more than 17% and Zhipu up 4% — plus defensive corners such as coal and traditional Chinese medicine. Tencent had no standalone negative and simply traded as sector beta, but for a second consecutive session money chose to route around it toward pure model names, confirming it still isn't in the front rank of AI-theme allocation.

Short-term · 1–3 weeks
Long Lean bullish

Maintaining the long. Today was sector beta rather than a company-specific negative, and RSI easing from 60.7 to 55.8 actually leaves the position more comfortable — amid a field of readings below 20 and above 70, Tencent is one of the few names whose risk can still be measured conventionally. The entry zone moves down from HK$468–480 to HK$460–472 near the 50-day at HK$454.16, with the stop held at HK$448 and the target at HK$535 below the 200-day. The weakness must be acknowledged: the gap to the 200-day widened from 8.9% to 11.7%, and for two straight sessions money has routed around it into pure model names, leaving the rerating catalyst still absent.

Entry HK$460~472Stop HK$448Target HK$535
Long-term · months+
Accumulate

A 17.2x multiple against 21.3% EPS growth and 15% revenue growth puts the PEG well under 1, WeChat's cash-flow stability is unmatched among Chinese platforms, and 53 analysts converging on 44.1% upside makes the discount consensus rather than controversy.

  • Without a standalone AI narrative, money keeps routing around it into pure model names
  • Game approvals and regulation remain policy variables that cannot be fully priced
  • The gap to the 200-day widened to 11.7%, slowing the intermediate trend repair
Signal BacktestCumulative +11.39%price itself +11.13%profitable since 07-04
  • 07-02LongHK$430.2 → open → HK$479.2+11.39%
Community Voices
  • 港股通 · Southbound sold HK$1.46B net, and money would rather chase MiniMax up 17% than touch Tencent at 17x. The market pays a premium for imagination and a discount for certainty; that ledger eventually reversesOriginal ↗
Institutional Views
  • 华尔街共识 · 53 analysts average a HK$690.65 target, about 44.1% above spot, at a 1.14 rating near strong buy — wider than yesterday's 41.2%

Rapid Scan (6 names)

TickerCloseChangeScoreDirectionOne-line take
1211 logo1211HKHK$90.1+0.28%6LongUp 0.28% though the week is down 2.5%, with RSI back to neutral at 51.8 and price slipping out of the strong zone above the 50-day at HK$86.46. The HK$125.23 consensus target implies 39.0% upside. Maintaining the long, but momentum has softened.
3690 logo3690HKHK$92.3+0.11%6LongEssentially flat at +0.11% with RSI at 65.7 holding above the 200-day at HK$88.91 after an 18.6% month; the easing-competition thesis is unchanged. Maintaining the long.
2899 logo2899HKHK$35.26-0.11%7LongEssentially flat at -0.11% with RSI firm at 66.0 after a 19.0% month; at 14.2x against 72.2% EPS growth and a HK$50.50 target implying 43.2% upside, gold is a natural hedge as risk aversion returns. Maintaining the long.
2269 logo2269HKHK$41.36-0.05%7LongEssentially flat at -0.05% with RSI at 66.7 above the 200-day at HK$35.20 after an 8.8% week, part of the same innovative-drug chain that firmed against the tape. Maintaining the long.
2888 logo2888HKHK$234.2-0.09%6LongEssentially flat at -0.09% with RSI at 63.4 and price just 2.4% below the HK$240.00 high; at 14.4x, a bank benefits from rising yields. Maintaining the long.
2476 logo2476HKHK$236+2.16%6LongUp 2.16% against the tape with a 22.2% week and RSI neutral at 49.4; the HK$533.42 consensus implies 126% upside though only seven analysts cover it, limiting its weight. PCB demand is resonating with AI hardware. Maintaining the long.
Stock Brief 2026-08-07: Daily U.S. & HK Market Analysis Archive · Quant Brief